ABCG2 and malignant colon neoplasm: Giampieri et al. [45] correlated a panel of stemness markers with clinical outcome in resected stage II and III colon cancer patients; ABCG2 was found to be among those genes with a higher “weight” in determining different prognoses: patients with higher expression of ABCG2 have a worse prognosis (time to relapse).